Want to join the conversation?
In 2Q16, $STJ posted Atrial Fibrillation product sales of $324MM, up 13% from 2Q15. Heart Failure product sales were $384MM, up 48% and sales of neuromodulation products were $140MM, up 19% from last year. Total cardiovascular sales were $319MM, up 1%. Total CRM sales were $395MM, up 8% from 2Q15.
$EXTR has been on an interesting uptrend, fundamentals kinda tricky but solid technical. Earnings 5th
Wow! $MCD scores again.